Holen Sie sich die Stockscreener-App
1.58
4.64%
0.07
Handel nachbörslich:
1.57
-0.01
-0.63%
Metavia Inc Aktie (MTVA) Neueste Nachrichten
MetaVia Company Profile & Introduction - Moomoo
MetaVia(MTVA) Stock Options Chain | Quotes & News - Moomoo
If You Invested $1,000 in Neurobo Pharmaceuticals Inc (NRBO) - Stock Titan
MetaVia Announces $4 Million At-The-Market Stock Offering - TipRanks
Form 424B5 MetaVia Inc For: 2 July By Investing.com - Investing.com UK
[8-K] MetaVia Inc. Reports Material Event - Stock Titan
Metavia (NASDAQ: MTVA) ups ATM offering limit to $4.0M - Stock Titan
MetaVia Inc. Financial Disclosures & SEC Filings - TradingView
OTC Markets Hosts Virtual Investor Presentation with HH Kim, CEO and President, and Marshall Woodworth, CFO of MetaVia, with David Bautz, PhD, Senior Analyst at Zacks SCR - scr.zacks.com
IMG, MTVA, USREF, TGL: These four stocks trade ex-reverse split on Friday - MSN
MetaVia (MTVA) Stock Forum and Discussion - Moomoo
Why MetaVia Stock Is Surging On Friday? - MSN
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - GlobeNewswire Inc.
MetaVia Inc. Actuals & Estimates (NASDAQ:MTVA) - TradingView
MetaVia (MTVA) price target increased by 1,000.00% to 159.88 - MSN
Enterprise value to revenue forward of MetaVia Inc. – NASDAQ:MTVA - TradingView
Enterprise value to EBITDA forward of MetaVia Inc. – NASDAQ:MTVA - TradingView
Price to sales forward of MetaVia Inc. – NASDAQ:MTVA - TradingView
MTVA Q1 2026 Earnings: Miss on EPS as Pre‑Revenue Biotech Focuses on PipelineEstimate Revision Count - dars.gov.et
MTVA: Promising obesity and MASH therapies approach key data and partnership milestones this year - TradingView
MetaVia Inc (MTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
METAVIA INC (MTVA) Stock Chart - ChartMill
Daily Brief Health Care: Viyash Scientific, Guangdong True Health Medical Technology Development, Island Pharmaceuticals , MetaVia and more - Smartkarma
Daily Brief United States: Boston Dynamics, SpaceX, Bloom Energy Corp, Life Time Group Holdings, Maison Solutions, CTW Cayman, Invesco S&P 500 Momentum ETF, MetaVia, Viomi Technology Co Ltd and more - Smartkarma
MetaVia Inc (MTVA) Institutional Confidence - TradingKey
MetaVia Inc (MTVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MetaVia Inc (MTVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MetaVia Inc (MTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MetaVia Inc (MTVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
MTVA: Vanoglipel and DA-1726 Data Presented at ADA 2026 Scientific Sessions - Smartkarma
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PR Newswire
MetaVia Inc (MTVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MetaVia Inc (MTVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MetaVia Inc (MTVA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MTVA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D Investment - newsline.com
MTVA Technical Analysis & ETF Price Forecast - Intellectia AI
MTVA: DA-1726 and vanoglipol show strong clinical and combination potential, with solid cash runway - TradingView
MTVA: Combination therapies show significant weight loss and metabolic benefits; trials fully funded - TradingView
MetaVia Inc. (MTVA) Surges Over 9%: Key Levels to Watch After Strong MoveSwing Trade Setups - newsline.com
MTVA Q1 2026 Earnings: EPS Miss Amidst Pre-Revenue Stage; Stock Declines 5%Earnings Surprise Score - newsline.com
MetaVia Shareholders Approve Equity Plan and Reverse Split - The Globe and Mail
H.C. Wainwright Maintains MetaVia(MTVA.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Get insights into the top gainers and losers of Tuesday's pre-market session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
MetaVia (MTVA) director awarded 17,186 RSUs vesting in 2027 - Stock Titan
MetaVia (MTVA) awards 17,186 stock units to board director - Stock Titan
MetaVia (MTVA) director gets 17,186 RSUs vesting in 2027 - Stock Titan
MetaVia (MTVA) director Jason Groves awarded 17,186 RSUs in equity grant - Stock Titan
MetaVia (MTVA) director Andrew Koven receives 17,186 deferred RSU grant - Stock Titan
MetaVia Inc. (MTVA) director receives 17,186-share restricted stock grant - Stock Titan
According to documents submitted to the U.S. Securities and Exchange Commission, shareholders of MetaVia Inc have approved a reverse stock split plan, with the specific ratio to be determined within the range of 1-for-5 to 1-for-22. - Bitget
MetaVia (NASDAQ: MTVA) investors back reverse split and equity plan changes - Stock Titan
MetaVia presents promising obesity and metabolic data at ADA 2026 - grafa.com
MTVA: All five business proposals, including a reverse stock split, were approved by shareholders - TradingView
MTVA: All five proposals, including director elections and a reverse stock split, were approved - TradingView
MetaVia Presents Promising DA-1726 and Vanoglipel Combination Data for Obesity and Metabolic Disease at ADA 2026 Sessions - Minichart
MetaVia highlights obesity and metabolic pipeline advancements - TipRanks
MetaVia (NASDAQ: MTVA) posts DA-1726 and vanoglipel obesity, MASH data - Stock Titan
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential - Lelezard
MetaVia reports obesity drug data at diabetes conference By Investing.com - Investing.com Canada
MetaVia's DA-1726 shows 9.1% weight loss at Day... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
MetaVia reports obesity drug data at diabetes conference - Investing.com
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):